MCAM and osteosarcoma: Furthermore, the in vitro targeting MCAM using antibodies altered the biological properties of endothelial, melanoma, breast, ovarian, adenoid cystic carcinoma, and osteosarcoma cells, such as the proliferation or survival, migration, and invasion [3,15,16,17,18,19,20,21,22,23].